Buy American panel discussion: How will this month's Executive Order impact drug and device companies, and what should you do about it?

On August 6, 2020, U.S. President Donald Trump issued his much-anticipated "Buy American" Executive Order (EO), aimed at shoring up domestic manufacture of "essential medicines", "medical...

Federal Contracting During the Global Pandemic – Key Issues for Pharma Companies

Joy Sturm, Allison Pugsley, and Ryan Harrigan, along with the Coalition for Government Procurement, presented a webinar about federal contracting during the global pandemic.

Paths for medical device companies to partner with the federal government

Tapping into the federal market in the COVID-19 environment

Federal Pricing and Reporting conference

The 11th annual Federal Pricing and Reporting conference took place in Philadelphia on 22 and 23 October 2019, and was attended by senior-level executives from pharmaceutical and biotech...

New Compliance Requirements for Pharmaceutical and Biologics Contractors webinar

Katie Lapins, Principal, Government Pricing Specialists, LLC and Joy Sturm, Partner, Hogan Lovells US LLP will discuss the new compliance requirements for pharmaceutical and biologics...

Loading data